Kratom Bans Reduce Severe Outcomes; Kratom Consumer Protection Acts Show No Benefit Over No Regulation

Why it matters

This peer-reviewed national study is the most comprehensive comparison to date of state kratom policies and their public health outcomes, providing policymakers with direct evidence on which regulatory approaches actually reduce hospitalizations and deaths.

The big picture

As kratom use rises across the U.S., states have taken wildly different approaches — from outright bans to Kratom Consumer Protection Acts (KCPA) to no regulation at all. Until now, there was limited data on which approach actually worked. This Medical College of Wisconsin study analyzed over a decade of poison center data to provide the clearest answer yet.

Key findings

• Kratom poison center exposures increased 69-fold from 2010 to 2023, with 8,919 total cases reported
• 13% of all kratom exposures resulted in severe medical outcomes
• States with kratom bans had 2.49x fewer exposures, 3.19x fewer severe outcomes, and 2.45x fewer hospitalizations than unregulated states
• KCPA states showed no statistically significant difference from unregulated states in rates of severe outcomes or hospitalization
• Severe outcomes rose from zero cases in 2010 to 158 cases in 2023, underscoring a rapidly worsening public health trend

What they say

The authors concluded: 'Kratom exposures and severe medical outcomes reported to United States poison centers are increasing nationally, though states with bans in place have experienced less pronounced increases.'

Bottom line

**A peer-reviewed national analysis finds kratom bans are associated with substantially fewer poisonings and hospitalizations, while Kratom Consumer Protection Acts offer no measurable safety advantage over no regulation.**